G protein coupled growth factor receptor tyrosine kinase: no longer an oxymoron

被引:10
作者
Ghosh, Pradipta [1 ]
机构
[1] Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA
关键词
girdin; GIV; G protein -coupled receptors; growth factor receptor tyrosine kinases; heterotrimeric G proteins; G-ALPHA-I; GIRDIN; ACTIVATION; GIV/GIRDIN; GIV; PHOSPHORYLATION; SIGNALS; MIGRATION; MOTILITY; GTPASE;
D O I
10.1080/15384101.2015.1066538
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Environmental cues are transmitted to the interior of the cell via a complex network of signaling hubs. Receptor tyrosine kinases (RTKs) and trimeric G proteins are 2 such major signaling hubs in eukaryotes. Canonical signal transduction via trimeric G proteins is spatially and temporally restricted, i.e., triggered exclusively at the plasma membrane (PM) by agonist activation of G-protein-coupled receptors (GPCRs) via a process that completes within a few hundred milliseconds. Recently, a rapidly emerging paradigm has revealed a non-canonical pathway for activation of trimeric G proteins by the non-receptor GEF, GIV/Girdin, that has distinctive temporal and spatial features. Such activation can be triggered by multiple growth factor RTKs, can occur at the PM and on internal membranes discontinuous with the PM, and can continue for prolonged periods of time. The molecular mechanisms that govern such non-canonical G protein activation and the relevance of this new paradigm in health and disease is discussed.
引用
收藏
页码:2561 / 2565
页数:5
相关论文
共 50 条
  • [21] Structural insights into G protein-coupled receptor kinase function
    Homan, Kristoff T.
    Tesmer, John J. G.
    CURRENT OPINION IN CELL BIOLOGY, 2014, 27 : 25 - 31
  • [22] Selective recruitment of G protein-coupled receptor kinases (GRKs) controls signaling of the insulin-like growth factor 1 receptor
    Zheng, Huiyuan
    Worrall, Claire
    Shen, Hongchang
    Issad, Tarik
    Seregard, Stefan
    Girnita, Ada
    Girnita, Leonard
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2012, 109 (18) : 7055 - 7060
  • [23] G Protein-Coupled Receptor Kinase-5 Attenuates Atherosclerosis by Regulating Receptor Tyrosine Kinases and 7-Transmembrane Receptors
    Wu, Jiao-Hui
    Zhang, Lisheng
    Fanaroff, Alexander C.
    Cai, Xinjiang
    Sharma, Krishn C.
    Brian, Leigh
    Exum, Sabrina T.
    Shenoy, Sudha K.
    Peppel, Karsten
    Freedman, Neil J.
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2012, 32 (02) : 308 - U325
  • [24] Platelet-derived growth factor promotes osteoblast proliferation by activating G-protein-coupled receptor kinase interactor-1
    Wu, You
    Zhang, Ying
    Yin, Qingshui
    Xia, Hong
    Wang, Jiajia
    MOLECULAR MEDICINE REPORTS, 2014, 10 (03) : 1349 - 1354
  • [25] The Rak/Frk tyrosine kinase associates with and internalizes the epidermal growth factor receptor
    Jin, L.
    Craven, R. J.
    ONCOGENE, 2014, 33 (03) : 326 - 335
  • [26] Diabetes and microvascular pathophysiology: role of epidermal growth factor receptor tyrosine kinase
    Matrougui, Khalid
    DIABETES-METABOLISM RESEARCH AND REVIEWS, 2010, 26 (01) : 13 - 16
  • [27] G protein-coupled receptor kinase 5 modifies cancer cell resistance to paclitaxel
    Lagman, Joann
    Sayegh, Paula
    Lee, Christina S.
    Sulon, Sarah M.
    Jacinto, Alec Z.
    Sok, Vanessa
    Peng, Natalie
    Alp, Deniz
    Benovic, Jeffrey L.
    So, Christopher H.
    MOLECULAR AND CELLULAR BIOCHEMISTRY, 2019, 461 (1-2) : 103 - 118
  • [28] Knockdown of protein tyrosine phosphatase receptor U inhibits growth and motility of gastric cancer cells
    Liu, Yongjie
    Zhu, Zhichuan
    Xiong, Zhiqi
    Zheng, Jing
    Hui, Zelan
    Qiu, Jiangfeng
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL PATHOLOGY, 2014, 7 (09): : 5750 - 5761
  • [29] G Protein-Coupled Receptor Kinase 2 as Novel Therapeutic Target in Fibrotic Diseases
    Li, Nan
    Shan, Shan
    Li, Xiu-Qin
    Chen, Ting-Ting
    Qi, Meng
    Zhang, Sheng-Nan
    Wang, Zi-Ying
    Zhang, Ling-Ling
    Wei, Wei
    Sun, Wu-Yi
    FRONTIERS IN IMMUNOLOGY, 2022, 12
  • [30] Epidermal Growth Factor Receptor (EGFR) Tyrosine Kinase Inhibitors from the Natural Origin: A Recent Perspective
    Patel, Harun M.
    Rane, Rajesh
    Thapliyal, Neeta
    Palkar, Mahesh
    Shaikh, Mahamadhanif
    Karpoormath, Rajshekhar
    ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY, 2015, 15 (08) : 988 - 1011